Skip to main content
ESPREsperion Therapeutics, Inc.Sell5.5·$3.16+0.00%
ESPR · Why this verdict

Why Esperion Therapeutics (ESPR) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.5/10
ConfidenceMEDIUM
MacroNEUTRAL

Per-dimension breakdown

Value

6.0/10data confidence 67%
ComponentSub-score
P/S9.0
EV/EBITDA2.5
Fwd P/E9.2
Analyst target3.0
  • Forward P/E: 10.8x

Quality

4.6/10data confidence 100%
ComponentSub-score
ROA8.0
Gross margin7.6
Op margin0.0
Net margin0.0
Current ratio5.6
FCF quality0.0
Moat7.0
Piotroski F8.9
  • Cash-burning: FCF -12% of revenue
  • Strong Piotroski F-Score: 8/9

Growth

8.3/10data confidence 33%
ComponentSub-score
Rev growth8.3
  • Strong growth: 23% YoY

Momentum

4.9/10data confidence 100%
ComponentSub-score
RSI5.5
MACD3.7
OBV4.1
MA position9.0
Volume2.3
  • Above 200-day MA

Sentiment

5.0/10data confidence 100%
ComponentSub-score
LLM sentiment5.0
Analyst rating5.0
Price target5.1

Insider

3.9/10data confidence 75%
ComponentSub-score
materiality4.5
insider conviction2.0
holder change5.1
  • Modest insider selling — $240,364 (0.030% of mkt cap)

Peer rank

5.5/10data confidence 80%
ComponentSub-score
value rank6.0
quality rank3.4
growth rank7.4

Technical

3.6/10data confidence 100%
ComponentSub-score
bollinger3.2
support resistance2.5
52w position5.1

Risk (lower is worse)

8.3/10data confidence 100%
ComponentSub-score
short interest5.9
days to cover8.7
volatility10.0
put call10.0
implied vol8.7
beta6.7

Catalyst

2.8/10data confidence 100%
ComponentSub-score
erm1.0
earnings history0.0
earnings timing5.0
surprise avg0.0
news activity8.0
  • Estimates down -35.2% (30d)
  • Earnings concerns: 1B/3M

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:4.9>=4.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:31d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.9=NEGATIVE
Warning (1)
  • MOMENTUM:4.9<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
-0.95
Upside
-14.2%
Downside
15.0%
Sizing output
AVOID

SetupRange Bound RSI 55 mid-range, Bollinger mid-band

EdgeNo clear edge No clear edge identified

SuitabilityAggressive MCap $0.8B<$5B

Investment implication

The F-path SELL output reflects an overall score of 5.5 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 8.3) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.9=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.95 — supplementary context, not the trigger for this path.

The strongest dimensions are Growth at 8.3, Risk (lower is worse) at 8.3, and Value at 6.0; the weakest are Catalyst at 2.8, Technical at 3.6, and Insider at 3.9. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.95 and an engine sizing output of AVOID.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks ESPR Why this verdict